CLINICAL-EVALUATION OF GLIMEPIRIDE (HOE490) IN NIDDM, INCLUDING A DOUBLE-BLIND COMPARATIVE-STUDY VERSUS GLICLAZIDE

Authors
TSUMURA K
Citation
K. Tsumura, CLINICAL-EVALUATION OF GLIMEPIRIDE (HOE490) IN NIDDM, INCLUDING A DOUBLE-BLIND COMPARATIVE-STUDY VERSUS GLICLAZIDE, Diabetes research and clinical practice, 28, 1995, pp. 147-149
Citations number
NO
Categorie Soggetti
Gastroenterology & Hepatology","Endocrynology & Metabolism
Journal title
Diabetes research and clinical practice → ACNP
ISSN journal
01688227
Volume
28
Year of publication
1995
Supplement
S
Pages
147 - 149
Database
ISI
SICI code
0168-8227(1995)28:<147:COG(IN>2.0.ZU;2-N
Abstract
In order to investigate the clinical usefulness of glimepiride in NIDD M, some clinical trials were conducted. In a double-blind comparative study versus gliclazide, glimepiride was as efficacious as gliclazide. However, a subgroup analysis suggested glimepiride may have been more effective in severe patients treated by large doses of glibenclamide.